SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Howse Curtis

(Last) (First) (Middle)
777 LONG RIDGE ROAD
C/O CORPORATE SECRETARY

(Street)
STAMFORD CT 06902

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2021
3. Issuer Name and Ticker or Trading Symbol
Synchrony Financial [ SYF ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See remarks
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 49,386(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) (2) 07/31/2024 Common Stock 73,879 23 D
Employee Stock Option (right to buy) (3) 09/17/2024 Common Stock 11,610 24.55 D
Employee Stock Option (right to buy) (4) 04/01/2025 Common Stock 8,577 30.41 D
Employee Stock Option (right to buy) (5) 04/01/2026 Common Stock 11,852 29.33 D
Employee Stock Option (right to buy) (6) 04/01/2027 Common Stock 12,086 34.3 D
Employee Stock Option (right to buy) (7) 04/01/2028 Common Stock 11,380 33.53 D
Explanation of Responses:
1. Represents 15,444 shares of Synchrony Financial ("Company") common stock, 9,136 restricted stock units that will vest on March 1, 2021, 4,100 restricted stock units that will vest on April 1, 2021, 1,786 restricted stock units that will vest on October 16, 2021, 9,136 restricted stock units that will vest on March 1, 2022, 2,627 restricted stock units that will vest on April 1, 2022, 5,839 restricted stock units that will vest on March 1, 2023, and 1,317 restricted stock units that will vest on April 1, 2023. Each restricted stock unit represents a contingent right to receive one share of Company common stock.
2. The reporting person was awarded 73,879 employee stock options on July 31, 2014, which vested in full on the fourth anniversary of the grant date.
3. The reporting person was awarded 11,610 employee stock options on September 17, 2014, which vested in five equal annual installments of 20% each, beginning on the first anniversary of the grant date.
4. The reporting person was awarded 8,577 employee stock options on April 1, 2015, which vested in five equal annual installments of 20% each, beginning on the first anniversary of the grant date.
5. The reporting person was awarded 11,852 employee stock options on April 1, 2016, which vest in five equal annual installments of 20% each, beginning on the first anniversary of the grant date.
6. The reporting person was awarded 12,086 employee stock options on April 1, 2017, which vest in five equal annual installments of 20% each, beginning on the first anniversary of the grant date.
7. The reporting person was awarded 11,380 employee stock options on April 1, 2018, which vest in five equal annual installments of 20% each, beginning on the first anniversary of the grant date.
Remarks:
Executive Vice President and Chief Executive Officer-Payment Solutions and Chief Commercial Officer Exhibit List: Exhibit 24 - Power of Attorney
/s/ Curtis Howse 01/08/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.